A G Bejinariu1, D U Härtel2, J Brockmeier2, R Oeckinghaus2, A Herzer2, U Tebbe2. 1. Clinic for Cardiology, Angiology and Intensive Care, Klinikum Lippe Detmold, Röntgenstr. 18, 32756, Detmold, Germany. alexandru.bejinariu@klinikum-lippe.de. 2. Clinic for Cardiology, Angiology and Intensive Care, Klinikum Lippe Detmold, Röntgenstr. 18, 32756, Detmold, Germany.
Abstract
BACKGROUND: Atrial fibrillation is associated with a high risk for thromboembolic events. Thrombi in the left atrial appendage and spontaneous echo contrast (SEC) correlate positively with this embolic risk. We studied the laboratory, echocardiographic, and epidemiologic parameters that could predict left atrial thrombi and the intensity of the SEC. PATIENTS AND METHODS: Between September 2013 and June 2015 we included 372 patients with atrial fibrillation before planned electrical cardioversion (transesophageal-guided strategy) in this study. After assessing the risk of stroke and bleeding (CHA2DS2-VASc and HAS-BLED scores), we measured the concentration of the D-dimer and B-type natriuretic peptide at the time of the transesophageal echocardiography as well as the left atrial volume and the ejection fraction during transthoracic echocardiography. RESULTS: The ejection fraction and the CHA2DS2-VASc score were identified as independent predictors of both left atrial thrombi and SEC, whereas the left atrial volume could only predict the intensity of SEC. In contrast to the results of other studies, the biomarkers in this study failed to predict the outcome. CONCLUSION: Only the echocardiographic and epidemiologic parameters were predictors of left atrial thrombi and SEC intensity, while the studied biomarkers had no predictive power. Using clinical data and transthoracic echocardiography, we can change the therapeutic strategy in high-risk patients.
BACKGROUND:Atrial fibrillation is associated with a high risk for thromboembolic events. Thrombi in the left atrial appendage and spontaneous echo contrast (SEC) correlate positively with this embolic risk. We studied the laboratory, echocardiographic, and epidemiologic parameters that could predict left atrial thrombi and the intensity of the SEC. PATIENTS AND METHODS: Between September 2013 and June 2015 we included 372 patients with atrial fibrillation before planned electrical cardioversion (transesophageal-guided strategy) in this study. After assessing the risk of stroke and bleeding (CHA2DS2-VASc and HAS-BLED scores), we measured the concentration of the D-dimer and B-type natriuretic peptide at the time of the transesophageal echocardiography as well as the left atrial volume and the ejection fraction during transthoracic echocardiography. RESULTS: The ejection fraction and the CHA2DS2-VASc score were identified as independent predictors of both left atrial thrombi and SEC, whereas the left atrial volume could only predict the intensity of SEC. In contrast to the results of other studies, the biomarkers in this study failed to predict the outcome. CONCLUSION: Only the echocardiographic and epidemiologic parameters were predictors of left atrial thrombi and SEC intensity, while the studied biomarkers had no predictive power. Using clinical data and transthoracic echocardiography, we can change the therapeutic strategy in high-risk patients.
Entities:
Keywords:
Atrial fibrillation; Cardioversion; Left atrium; Thrombus; Transesophageal echocardiography
Authors: Rahul Malik; Daniel M Alyeshmerni; Zuyue Wang; Steven A Goldstein; Rebecca Torguson; Joseph Lindsay; Ron Waksman; Itsik Ben-Dor Journal: Cardiovasc Revasc Med Date: 2014-12-27
Authors: Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy Journal: J Am Coll Cardiol Date: 2014-03-28 Impact factor: 24.094
Authors: Morten Lock Hansen; Rikke Malene H G Jepsen; Jonas Bjerring Olesen; Martin Huth Ruwald; Deniz Karasoy; Gunnar Hilmar Gislason; Jim Hansen; Lars Køber; Steen Husted; Christian Torp-Pedersen Journal: Europace Date: 2014-09-17 Impact factor: 5.214
Authors: Maura M Zylla; Mara Pohlmeier; Alexander Hess; Derliz Mereles; Meinhard Kieser; Thomas Bruckner; Eberhard Scholz; Edgar Zitron; Patrick A Schweizer; Hugo A Katus; Dierk Thomas Journal: Am J Cardiol Date: 2014-12-18 Impact factor: 2.778
Authors: F Zoppo; G Brandolino; A Berton; N Frigato; M Michieletto; A Zanocco; F Zerbo; E Bacchiega; A Lupo; E Bertaglia Journal: J Interv Card Electrophysiol Date: 2012-08-07 Impact factor: 1.900
Authors: Sebastian Feickert; Giuseppe D Ancona; Hüseyin Ince; Kristof Graf; Elias Kugel; Monica Murero; Erdal Safak Journal: J Atr Fibrillation Date: 2020-10-31
Authors: J Huang; S L Wu; Y M Xue; H W Fei; Q W Lin; S Q Ren; H T Liao; X Z Zhan; X H Fang; L Xu Journal: Biomed Res Int Date: 2017-03-08 Impact factor: 3.411
Authors: Jose L Merino; Gregory Y H Lip; Hein Heidbuchel; Aron-Ariel Cohen; Raffaele De Caterina; Joris R de Groot; Michael D Ezekowitz; Jean-Yves Le Heuzey; Sakis Themistoclakis; James Jin; Michael Melino; Shannon M Winters; Béla Merkely; Andreas Goette Journal: Europace Date: 2019-11-01 Impact factor: 5.214